Get your groove on! Cockatoos have 30 distinct dance moves
Some wild birds display rhythmic movements as part of courtship displays to try and find a mate. Dancing requires a lot of complicated brain processes including imitation, learning and moving in time to music. Several species of parrot have been observed dancing to music in captivity and researchers analysed 45 social media videos showing cockatoos dancing as part of the study. The 17 new moves haven't been described scientifically before, including body rolls, side-stepping and head-banging.The researchers found that some birds also performed their own individual dance moves and each species had its own most common moves.
The researchers also looked at dancing behaviour in six cockatoos from three species at Wagga Wagga Zoo in Australia. They found that whether they were playing music or not, all birds performed dance moves. The study shows it's more common in cockatoos than previously thought.At least 10 out of the 21 species of cockatoo can throw shapes and many have a wide range of dance moves. The scientists think their abilities may have come from their courtship behaviour and they argue it shows how intelligent the birds really are. They added that dance behaviour can be a good indicator of birds' emotions and that playing music to parrots could help to enrich their lives.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Telegraph
14 minutes ago
- Telegraph
Snail's ability to regrow eyes raises hope for blind humans
A snail's ability to regrow its eyes after they have been cut off could one day see humans create a cure for some forms of blindness. The apple snail has the unique ability to regenerate its eyes, which are a complex organ like those of people. Scientists studying the regrowth process discovered the gene likely responsible for the optical revival in the mollusc is called pax6 and is also found in humans. 'Our studies reveal that, akin to humans, pax6 is indispensable for eye development in apple snails, establishing this as a research organism to unravel the mechanisms of camera-type eye regeneration,' the scientists write in their study. 'This work expands our understanding of complex sensory organ regeneration and offers a way to explore this process.' The scientists hope to study this gene in further detail to see if the gene could offer routes to future therapies in people to treat humans with eye injuries causing sight issues in the future. Snails have been known to regrow their heads since the 18th century but the latest work is the first to fully identify the eye-specific regeneration of the animal. The apple snail is the only animal with a camera-type eyeball that is known to be able to regenerate the sight organ. This type of eye has a cornea, a lens and a retina and are found in all vertebrates as well as spiders, squid and some snails. 'We did a lot of work to show that many genes that participate in human eye development are also present in the snail,' said study author Dr Alice Accorsi, assistant professor of molecular and cellular biology at the University of California, Davis. 'After regeneration, the morphology and gene expression of the new eye is pretty much identical to the original one.' The study found that the snails regrew the eye components in 15 days and then these matured for several more weeks, but Dr Accorsi said there is no conclusive evidence the snails can actually see through the new eye. Future work will try and confirm if they can. The study found the pax6 gene to be key in how eyes develop, and a follow up will see if it is also instrumental in regeneration. 'If we find a set of genes that are important for eye regeneration, and these genes are also present in vertebrates, in theory we could activate them to enable eye regeneration in humans,' Dr Accorsi said.
The Independent
2 hours ago
- The Independent
Million-year-old stone tools found on Indonesian island could unravel mystery of ‘hobbit' humans
Humans may have crossed mainland Southeast Asia to occupy surrounding islands much earlier than previously thought, according to a new study that sheds more light on the origin of the Flores 'hobbit' species. The hobbit, Homo floresiensis, was a small-bodied human species that likely emerged from the Homo erectus after they had crossed the marine barrier around Southeast Asia to inhabit Indonesia's Flores island a million years ago. Homo erectus likely underwent hundreds of thousands of years of dwarfism on that isolated island to evolve into the hobbit species. But exactly how this might have happened is a mystery researchers say million-year-old stone tools found on Indonesia's Sulawesi island could help unravel. The tools include sharp-edged stone fragments that the ancient humans made from larger pebbles likely taken from nearby riverbeds. Previous research suggested that the Wallacea archipelago was occupied from at least 1.02 million years ago, based on the presence of stone tools at Wolo Sege on Flores, while Talepu on Sulawesi was inhabited around 194 thousand years ago. The latest find at Calio indicates early humans reached Sulawesi far earlier than thought, 'at around the same time as Flores, if not earlier'. The stone artefacts point to the island being a tool-making site and a hunting ground nearly 1.04 million years ago. 'Sulawesi is a wild card. It is like a mini-continent in itself,' study co-author Adam Brumm said. 'This discovery adds to our understanding of the movement of extinct humans across the Wallace Line, a transitional zone beyond which unique and often quite peculiar animal species evolved in isolation.' The findings also raise questions about the evolution of the 'hobbit' humans. 'If hominins were cut off on this huge and ecologically rich island for a million years, would they have undergone the same evolutionary changes as the Flores hobbits? Or would something totally different have happened?' Dr Brumm said. 'It's a significant piece of the puzzle but the Calio site has yet to yield any hominin fossils. So while we now know there were tool-makers on Sulawesi a million years ago, their identity remains a mystery.'
The Sun
2 hours ago
- The Sun
Common pill taken by millions could ‘slash your risk of dementia and dying young'
A CHEAP pill already taken by millions of patients could slash your risk of dementia and early death, scientists say. This is none other than metformin, "the most widely prescribed drug for type 2 diabetes", according to researchers from Taipei Medical University in Taiwan. 1 They found that people who were taking the treatment were less likely to develop memory-robbing dementia or die from any cause. The results were based on a study of 452,777 adults who were either overweight or obese, published in Diabetes, Obesity and Metabolism. Obesity and diabetes have both been shown to up the risk of dementia. Some studies report that diabetics have a 70 per cent higher risk of getting the condition, compared to those without diabetes. Meanwhile, being obese between the ages of 35-65 can increase dementia risk in later-life by about 30 per cent. Metformin is the most common treatment for type 2 diabetes, which affects over 5 million Brits, according to Diabetes UK. The drug is also used to help prevent type 2 diabetes in people at high risk of developing it. It works by curbing the amount of sugar pumped around the body by the liver and helping the insulin you produce work better. "Metformin has many advantages over other diabetic drugs. It has strong glucose-lowering effects, a reliable safety profile and is relatively cheap," researchers said. "Metformin also reduces the likelihood of dementia in patients with diabetes." Common painkiller used for back pain ups risk of dementia by 29%, scientists warn But some studies suggest the drug doesn't protect against dementia, as it can cause vitamin B12 deficiency, which has been linked to cognitive decline. It could increase the risk of Alzheimer's, a type of dementia, research suggests. "Whether metformin's beneficial effects in patients with dementia can be applied to the general population is unclear," the study authors noted. The study included about 905,000 people in total, split evenly into two groups: metformin users and non-metformin users. They were matched to be similar in age, health, and other factors for a fair comparison. The metformin group had been prescribed the drug at least twice in their lives, for at least six months. Researchers categorised study participants by their body mass index (BMI) as: Overweight: BMI 25–29.9 Obese class I: BMI 30–34.9 Obese class II: BMI 35–39.9 Morbidly obese: BMI over 40 They followed patients for 10 years and found that those who took metformin had a lower risk of developing dementia, regardless of their BMI. Class I and II obese patients saw the greatest reduction in risk - 8 and 4 per cent respectively, compared to people who didn't take metformin. Manage blood sugar levels Strictly follow a diabetes management plan, as prescribed by a healthcare professional. This includes medication, diet and exercise. Regularly monitor blood sugar levels and manage insulin appropriately. Adopt a healthy lifestyle Follow a balanced diet in fruits, vegetables, whole grains, and lean protein, with limited saturated fat, sugar, and salt. Aim for at least 150 minutes of moderate-intensity exercise per week. Being overweight or obese can increase the risk of type 2 diabetes and other conditions linked to dementia. Weight management through diet and exercise can help mitigate these risks. Engage in activities that challenge your mind, such as puzzles, reading, learning new skills, or socialising. Address other risk factors High blood pressure and cholesterol can damage blood vessels, increasing the risk of both cardiovascular disease and dementia. Regular check-ups and appropriate treatment are essential. Excessive alcohol consumption can negatively impact brain health. Moderate drinking or abstaining from alcohol can be beneficial. Hearing loss can contribute to cognitive decline. Addressing hearing problems through hearing aids or other interventions can help maintain cognitive function. Seek professional guidance Regular medical check-ups are important for monitoring overall health and identifying and addressing potential risk factors early on. Work with your doctor, diabetes educator, or other healthcare professionals to develop a personalized plan for managing your diabetes and reducing your risk of dementia. Researchers said the drug's ability to lower inflammation in obese patients may have something to do with this. "Since central nervous system inflammation and neuroinflammation are crucial factors in the development and progression of neurodegenerative diseases, the anti-inflammatory and antioxidative effects of metformin are especially beneficial in patients with obesity," they wrote. "We observed that the protective effect of metformin against dementia was consistent across all BMI categories greater than 25." Metformin-users also had a lower risk of early death, between 28 and 26 per cent. "This study is strong because it included a large sample of metformin users and patients with obesity and dementia, using data from more than 184 million patients worldwide," researchers said. "The use of real-world data allows for a better understanding of how treatments perform in a heterogeneous population because the data are captured from diverse, real-life settings. "Therefore, the findings of this study can be readily generalised to whole populations." But they acknowledge that their study had certain limitations too, including that the dataset only covered a 10 year period, restricting researchers' ability to evaluate the long-term effects of metformin. They concluded: "Our study findings indicate that metformin may help reduce the risk of dementia in obese patients, which could further contribute to improving all-cause mortality. "However, further research is required to explore the mechanisms by which metformin reduces the risk of dementia." Experts have previously suggested that using metformin to help treat dementia could cut costs. Dr Sara Imarisio, who used to be head of research at Alzheimer's Research UK, said: 'Repurposing an existing drug used for another health condition would be a cheaper and inexpensive way to bring about a new dementia treatment. 'Diabetes is a risk factor for dementia and there is a lot of interest in the links between the two conditions." But recent research suggests that weight-loss jabs are better at curbing dementia risk in people with type 2 diabetes than metformin. Metformin is generally the first-line medication for type 2 diabetes, while GLP-1 receptor agonists are often used as second-line or add-on therapy when metformin is not sufficient or tolerated. Early signs of dementia It's not unusual for your memory to lapse a bit as you get older. But dementia is different from 'just getting old' as it will cause noticeable - rather than gradual - changes to mental abilities and make managing everyday tasks and activities increasingly difficult. The symptoms of dementia may be small to start with, but get worse over time. Below are some examples of possible signs. Memory loss Memory loss is a key sign of dementia. This can include: Forgetting something you were only recently told. You may ask for the same information repeatedly – for example, 'Are the doors locked?' Putting objects in unusual places – for example, putting your house keys in the refrigerator. Being unable to learn new tasks, like how to use a new washing machine. Planning and decision making issues People with dementia can have difficulty with planning and decision making. This can include: Getting very confused when planning or thinking things through. Struggling to stay focused on a single task. Not making informed, careful decisions when dealing with money or looking at risks. Finding it hard to manage regular payments, budgets or monthly bills. Problems with language and understanding In people with dementia, this can manifest as: Having frequent problems finding the right word or regularly referring to objects as 'that thing'. Finding it hard to take part in conversations. Regularly being unable to follow what someone is saying even without distractions. Losing sense of time and place Dementia can cause problems with orientation, including: Losing track of the date, season or the passage of time. Getting lost in a place that is familiar or that should be easy to find your way around – for example, a supermarket. Regularly being unable to follow what someone is saying even without distractions. Problems with vision and perception This can mean having problems making sense of what you see. For example, having difficulty judging distances on stairs, or mistaking reflections or patterns for other objects. Mood and behavioural changes Finally, dementia can also make people act differently or shift their mood. This can mean: Becoming withdrawn and losing interest in work, friends or hobbies. Feeling unusually sad, anxious, frightened or low in confidence. Getting easily upset at home, at work, with friends or in places that usually feel comfortable or familiar.
